What is he best known for?
The fields of study he is best known for:
His primary areas of study are Genetics, Cancer, Gene, Mutation and Cancer research.
His Disease research extends to the thematically linked field of Genetics.
His research in Cancer intersects with topics in Wnt signaling pathway, Oncology and Bioinformatics.
His work on Germline mutation, IDH1 and IDH2 as part of general Mutation research is often related to Isocitrate dehydrogenase, thus linking different fields of science.
His work deals with themes such as Missense mutation, Enasidenib, Nonsynonymous substitution, Immunology and Colorectal cancer, which intersect with Cancer research.
His study looks at the intersection of Breast cancer and topics like Genetic testing with Family history and Ovarian cancer.
His most cited work include:
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme (4410 citations)
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (3039 citations)
- Genomic landscapes of human breast and colorectal cancers (2656 citations)
What are the main themes of his work throughout his whole career to date?
Giovanni Parmigiani mostly deals with Genetics, Internal medicine, Cancer, Oncology and Statistics.
His Genetics study is mostly concerned with Gene, Mutation, Genome, Genetic testing and Human genome.
His Gene research incorporates themes from Cancer research and Computational biology.
His biological study spans a wide range of topics, including Germline mutation and Bioinformatics.
Many of his research projects under Statistics are closely connected to Context with Context, tying the diverse disciplines of science together.
The concepts of his Breast cancer study are interwoven with issues in Penetrance and Family history.
He most often published in these fields:
- Genetics (15.54%)
- Internal medicine (14.72%)
- Cancer (14.11%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (14.72%)
- Oncology (13.29%)
- Cancer (14.11%)
In recent papers he was focusing on the following fields of study:
Giovanni Parmigiani mainly focuses on Internal medicine, Oncology, Cancer, Multiple myeloma and Computational biology.
His study on Oncology also encompasses disciplines like
- Breast cancer that connect with fields like Receiver operating characteristic,
- Prostate cancer that connect with fields like PTEN and Prostate.
His Cancer study combines topics in areas such as Germline mutation, Penetrance, Gene and Family history.
Giovanni Parmigiani combines subjects such as Unknown Significance, Genetics, Genetic testing and Genetic predisposition with his study of Family history.
Many of his studies involve connections with topics such as Cohort and Genetics.
His Multiple myeloma research also works with subjects such as
- Cancer research, which have a strong connection to Carcinogenesis, Stroma, Ovarian tumor, Tumor microenvironment and Gene expression profiling,
- Somatic cell that intertwine with fields like Coding.
Between 2016 and 2021, his most popular works were:
- Adaptive platform trials: definition, design, conduct and reporting considerations. (64 citations)
- Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis. (48 citations)
- Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer (48 citations)
In his most recent research, the most cited papers focused on:
Giovanni Parmigiani mainly investigates Internal medicine, Oncology, Clinical trial, MEDLINE and Meta-analysis.
In general Internal medicine study, his work on Disease, Confidence interval, Odds ratio and Cystadenocarcinoma often relates to the realm of Neoplasm Grading, thereby connecting several areas of interest.
His Oncology study integrates concerns from other disciplines, such as Concordance, Cancer, Breast cancer and Hazard ratio.
His Cancer research integrates issues from Regulation of gene expression and Gene signature.
His studies deal with areas such as Germline, Randomized controlled trial, Surgery and Bioinformatics as well as MEDLINE.
His Gene research is multidisciplinary, relying on both Colorectal cancer, Computational biology and Multiple myeloma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
